Clusterin for use in the treatment of thrombotic microangiopathies
US-12186366-B2 · Jan 7, 2025 · US
Inserm—Institut National De La Sante Et De La Rech Medicale holds 13 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 13 |
| Recent patents | 5 |
| First publication | Dec 25, 2018 |
| Latest publication | Jan 7, 2025 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12186366-B2 · Jan 7, 2025 · US
US-12083091-B2 · Sep 10, 2024 · US
US-11851496-B2 · Dec 26, 2023 · US
US-11756689-B2 · Sep 12, 2023 · US
US-11732262-B2 · Aug 22, 2023 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12186366-B2 · Jan 7, 2025 · US
US-12083091-B2 · Sep 10, 2024 · US
US-11851496-B2 · Dec 26, 2023 · US
US-11756689-B2 · Sep 12, 2023 · US
US-11732262-B2 · Aug 22, 2023 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 11 |
| Physics | 7 |
| Chemistry & Metallurgy | 3 |
| Cross-Sectional Technologies | 1 |
Answers are generated from the same data shown on this page.